共 50 条
[11]
Apatinib and irinotecan combination treatment in first-line chemotherapy refractory esophageal squamous cell carcinoma: A phase I dose escalation study
[J].
Jia, J.
;
Yu, J.
;
Sun, Z.
;
Yang, Y.
;
Liu, C.
;
Xiao, Y.
;
Zhang, X.
.
ANNALS OF ONCOLOGY,
2017, 28

Jia, J.
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, VIP GI Div 2, Med Dept, Canc Hosp,Beijing Canc Hosp, Beijing, Peoples R China Peking Univ, VIP GI Div 2, Med Dept, Canc Hosp,Beijing Canc Hosp, Beijing, Peoples R China

Yu, J.
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, VIP GI Div 2, Med Dept, Canc Hosp,Beijing Canc Hosp, Beijing, Peoples R China Peking Univ, VIP GI Div 2, Med Dept, Canc Hosp,Beijing Canc Hosp, Beijing, Peoples R China

Sun, Z.
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, VIP GI Div 2, Med Dept, Canc Hosp,Beijing Canc Hosp, Beijing, Peoples R China Peking Univ, VIP GI Div 2, Med Dept, Canc Hosp,Beijing Canc Hosp, Beijing, Peoples R China

Yang, Y.
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, VIP GI Div 2, Med Dept, Canc Hosp,Beijing Canc Hosp, Beijing, Peoples R China Peking Univ, VIP GI Div 2, Med Dept, Canc Hosp,Beijing Canc Hosp, Beijing, Peoples R China

Liu, C.
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, VIP GI Div 2, Med Dept, Canc Hosp,Beijing Canc Hosp, Beijing, Peoples R China Peking Univ, VIP GI Div 2, Med Dept, Canc Hosp,Beijing Canc Hosp, Beijing, Peoples R China

Xiao, Y.
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, VIP GI Div 2, Med Dept, Canc Hosp,Beijing Canc Hosp, Beijing, Peoples R China Peking Univ, VIP GI Div 2, Med Dept, Canc Hosp,Beijing Canc Hosp, Beijing, Peoples R China

Zhang, X.
论文数: 0 引用数: 0
h-index: 0
机构:
Peking Univ, VIP GI Div 2, Med Dept, Canc Hosp,Beijing Canc Hosp, Beijing, Peoples R China Peking Univ, VIP GI Div 2, Med Dept, Canc Hosp,Beijing Canc Hosp, Beijing, Peoples R China
[12]
Phase II trial of paclitaxel and cisplatin combination given biweekly as first-line chemotherapy in patients with advanced or metastatic squamous cell carcinoma of esophagus from a single center in China.
[J].
Zhou, Y.
;
Huang, J.
;
Yang, L.
;
Cai, G. R.
;
Xu, H. B.
;
Wang, W. J.
;
Shi, K. Y.
;
Sun, Y.
.
JOURNAL OF CLINICAL ONCOLOGY,
2011, 29 (15)

Zhou, Y.
论文数: 0 引用数: 0
h-index: 0
机构:
Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China

Huang, J.
论文数: 0 引用数: 0
h-index: 0
机构:
Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China

Yang, L.
论文数: 0 引用数: 0
h-index: 0
机构:
Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China

Cai, G. R.
论文数: 0 引用数: 0
h-index: 0
机构:
Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China

Xu, H. B.
论文数: 0 引用数: 0
h-index: 0
机构:
Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China

Wang, W. J.
论文数: 0 引用数: 0
h-index: 0
机构:
Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China

Shi, K. Y.
论文数: 0 引用数: 0
h-index: 0
机构:
Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China

Sun, Y.
论文数: 0 引用数: 0
h-index: 0
机构:
Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China
[13]
Phase II study of irinotecan and cisplatin as first-line chemotherapy in advanced or recurrent cervical cancer
[J].
Sugiyama, T
;
Yakushiji, M
;
Noda, K
;
Ikeda, M
;
Kudoh, R
;
Yajima, A
;
Tomoda, Y
;
Terashima, Y
;
Takeuchi, S
;
Hiura, M
;
Saji, F
;
Takahashi, T
;
Umesaki, N
;
Sato, S
;
Hatae, M
;
Ohashi, Y
.
ONCOLOGY,
2000, 58 (01)
:31-37

Sugiyama, T
论文数: 0 引用数: 0
h-index: 0
机构: Kurume Univ, Sch Med, Dept Obstet & Gynecol, Kurume, Fukuoka 8300011, Japan

Yakushiji, M
论文数: 0 引用数: 0
h-index: 0
机构: Kurume Univ, Sch Med, Dept Obstet & Gynecol, Kurume, Fukuoka 8300011, Japan

Noda, K
论文数: 0 引用数: 0
h-index: 0
机构: Kurume Univ, Sch Med, Dept Obstet & Gynecol, Kurume, Fukuoka 8300011, Japan

论文数: 引用数:
h-index:
机构:

Kudoh, R
论文数: 0 引用数: 0
h-index: 0
机构: Kurume Univ, Sch Med, Dept Obstet & Gynecol, Kurume, Fukuoka 8300011, Japan

Yajima, A
论文数: 0 引用数: 0
h-index: 0
机构: Kurume Univ, Sch Med, Dept Obstet & Gynecol, Kurume, Fukuoka 8300011, Japan

Tomoda, Y
论文数: 0 引用数: 0
h-index: 0
机构: Kurume Univ, Sch Med, Dept Obstet & Gynecol, Kurume, Fukuoka 8300011, Japan

Terashima, Y
论文数: 0 引用数: 0
h-index: 0
机构: Kurume Univ, Sch Med, Dept Obstet & Gynecol, Kurume, Fukuoka 8300011, Japan

Takeuchi, S
论文数: 0 引用数: 0
h-index: 0
机构: Kurume Univ, Sch Med, Dept Obstet & Gynecol, Kurume, Fukuoka 8300011, Japan

Hiura, M
论文数: 0 引用数: 0
h-index: 0
机构: Kurume Univ, Sch Med, Dept Obstet & Gynecol, Kurume, Fukuoka 8300011, Japan

Saji, F
论文数: 0 引用数: 0
h-index: 0
机构: Kurume Univ, Sch Med, Dept Obstet & Gynecol, Kurume, Fukuoka 8300011, Japan

Takahashi, T
论文数: 0 引用数: 0
h-index: 0
机构: Kurume Univ, Sch Med, Dept Obstet & Gynecol, Kurume, Fukuoka 8300011, Japan

Umesaki, N
论文数: 0 引用数: 0
h-index: 0
机构: Kurume Univ, Sch Med, Dept Obstet & Gynecol, Kurume, Fukuoka 8300011, Japan

Sato, S
论文数: 0 引用数: 0
h-index: 0
机构: Kurume Univ, Sch Med, Dept Obstet & Gynecol, Kurume, Fukuoka 8300011, Japan

Hatae, M
论文数: 0 引用数: 0
h-index: 0
机构: Kurume Univ, Sch Med, Dept Obstet & Gynecol, Kurume, Fukuoka 8300011, Japan

论文数: 引用数:
h-index:
机构:
[14]
Docetaxel/cisplatin as first-line chemotherapy in patients with head and neck carcinoma - A phase II trial
[J].
Baur, M
;
Kienzer, HR
;
Schweiger, J
;
DeSantis, M
;
Gerber, E
;
Pont, J
;
Hudec, M
;
Schratter-Sehn, AU
;
Wicke, W
;
Dittrich, C
.
CANCER,
2002, 94 (11)
:2953-2958

Baur, M
论文数: 0 引用数: 0
h-index: 0
机构: Kaiser Franz Josef Spital, Ludwig Boltzmann Inst Appl Canc Res, Med Dept Oncol 3, A-1100 Vienna, Austria

Kienzer, HR
论文数: 0 引用数: 0
h-index: 0
机构: Kaiser Franz Josef Spital, Ludwig Boltzmann Inst Appl Canc Res, Med Dept Oncol 3, A-1100 Vienna, Austria

Schweiger, J
论文数: 0 引用数: 0
h-index: 0
机构: Kaiser Franz Josef Spital, Ludwig Boltzmann Inst Appl Canc Res, Med Dept Oncol 3, A-1100 Vienna, Austria

DeSantis, M
论文数: 0 引用数: 0
h-index: 0
机构: Kaiser Franz Josef Spital, Ludwig Boltzmann Inst Appl Canc Res, Med Dept Oncol 3, A-1100 Vienna, Austria

Gerber, E
论文数: 0 引用数: 0
h-index: 0
机构: Kaiser Franz Josef Spital, Ludwig Boltzmann Inst Appl Canc Res, Med Dept Oncol 3, A-1100 Vienna, Austria

Pont, J
论文数: 0 引用数: 0
h-index: 0
机构: Kaiser Franz Josef Spital, Ludwig Boltzmann Inst Appl Canc Res, Med Dept Oncol 3, A-1100 Vienna, Austria

Hudec, M
论文数: 0 引用数: 0
h-index: 0
机构: Kaiser Franz Josef Spital, Ludwig Boltzmann Inst Appl Canc Res, Med Dept Oncol 3, A-1100 Vienna, Austria

Schratter-Sehn, AU
论文数: 0 引用数: 0
h-index: 0
机构: Kaiser Franz Josef Spital, Ludwig Boltzmann Inst Appl Canc Res, Med Dept Oncol 3, A-1100 Vienna, Austria

Wicke, W
论文数: 0 引用数: 0
h-index: 0
机构: Kaiser Franz Josef Spital, Ludwig Boltzmann Inst Appl Canc Res, Med Dept Oncol 3, A-1100 Vienna, Austria

Dittrich, C
论文数: 0 引用数: 0
h-index: 0
机构: Kaiser Franz Josef Spital, Ludwig Boltzmann Inst Appl Canc Res, Med Dept Oncol 3, A-1100 Vienna, Austria
[15]
First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 study
[J].
Li, Jin
;
Chen, Zhendong
;
Bai, Yuxian
;
Liu, Bo
;
Li, Qingshan
;
Zhang, Jingdong
;
Zhou, Jun
;
Deng, Ting
;
Zhou, Fuyou
;
Gao, Shegan
;
Yang, Shujun
;
Ye, Feng
;
Chen, Long
;
Bai, Wei
;
Yin, Xianli
;
Cang, Shundong
;
Liu, Lianke
;
Pan, Yueyin
;
Luo, Hui
;
Ji, Yanxia
;
Zhang, Zhen
;
Wang, Jufeng
;
Yang, Quanliang
;
Li, Na
;
Huang, Rong
;
Qu, Chenglin
;
Ni, Jing
;
Wang, Bo
;
Xu, Yan
;
Hu, Jin
;
Shi, Qingmei
;
Yang, Jason
.
NATURE MEDICINE,
2024, 30 (03)
:740-748

Li, Jin
论文数: 0 引用数: 0
h-index: 0
机构:
Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Chen, Zhendong
论文数: 0 引用数: 0
h-index: 0
机构:
Anhui Med Univ, Dept Oncol, Hosp 2, Hefei, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Bai, Yuxian
论文数: 0 引用数: 0
h-index: 0
机构:
Harbin Med Univ, Canc Hosp, Dept Oncol, Harbin, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Liu, Bo
论文数: 0 引用数: 0
h-index: 0
机构:
Shandong Canc Hosp & Inst, Dept Digest, Jinan, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Li, Qingshan
论文数: 0 引用数: 0
h-index: 0
机构:
Chengde Med Univ, Dept Oncol, Affiliated Hosp, Chengde, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Zhang, Jingdong
论文数: 0 引用数: 0
h-index: 0
机构:
Liaoning Canc Hosp & Inst, Dept Digest, Shenyang, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Zhou, Jun
论文数: 0 引用数: 0
h-index: 0
机构:
Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Deng, Ting
论文数: 0 引用数: 0
h-index: 0
机构:
Tianjin Med Univ, Dept GI Med Oncol, Canc Inst & Hosp, Tianjin, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Zhou, Fuyou
论文数: 0 引用数: 0
h-index: 0
机构:
Anyang Canc Hosp, Dept Thorac Surg, Anyang, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Gao, Shegan
论文数: 0 引用数: 0
h-index: 0
机构:
Henan Univ Sci & Technol, Dept Oncol, Affiliated Hosp 1, Luoyang, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Yang, Shujun
论文数: 0 引用数: 0
h-index: 0
机构:
Henan Canc Hosp, Dept Oncol, Zhengzhou, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Ye, Feng
论文数: 0 引用数: 0
h-index: 0
机构:
Xiamen Univ, Dept Med Oncol, Affiliated Hosp 1, Xiamen, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Chen, Long
论文数: 0 引用数: 0
h-index: 0
机构:
Guangxi Med Univ, Affiliated Tumor Hosp, Dept Radiotherapy, Nanning, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Bai, Wei
论文数: 0 引用数: 0
h-index: 0
机构:
Shanxi Canc Hosp, Dept Digest, Taiyuan, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Yin, Xianli
论文数: 0 引用数: 0
h-index: 0
机构:
Hunan Canc Hosp, Dept Digest & Urol, Changsha, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Cang, Shundong
论文数: 0 引用数: 0
h-index: 0
机构:
Henan Prov Peoples Hosp, Dept Oncol, Zhengzhou, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Liu, Lianke
论文数: 0 引用数: 0
h-index: 0
机构:
Jiangsu Prov Hosp, Dept Oncol, Nanjing, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Pan, Yueyin
论文数: 0 引用数: 0
h-index: 0
机构:
Anhui Prov Hosp, Dept Oncol Chemotherapy, Hefei, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Luo, Hui
论文数: 0 引用数: 0
h-index: 0
机构:
Jiangxi Canc Hosp, Dept Thorac Tumor Radiotherapy, Nanchang, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Ji, Yanxia
论文数: 0 引用数: 0
h-index: 0
机构:
Handan Cent Hosp, Dept Oncol, Handan, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Zhang, Zhen
论文数: 0 引用数: 0
h-index: 0
机构:
Nanyang First Peoples Hosp, Dept Oncol, Nanyang, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Wang, Jufeng
论文数: 0 引用数: 0
h-index: 0
机构:
Henan Canc Hosp, Dept Digest, Zhengzhou, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Yang, Quanliang
论文数: 0 引用数: 0
h-index: 0
机构:
Changzhou Canc Hosp, Dept Oncol, Changzhou, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Li, Na
论文数: 0 引用数: 0
h-index: 0
机构:
Suining Cent Hosp, Dept Oncol, Suining, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Huang, Rong
论文数: 0 引用数: 0
h-index: 0
机构:
First Peoples Hosp Foshan, Dept Genitourinary Oncol, Foshan, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Qu, Chenglin
论文数: 0 引用数: 0
h-index: 0
机构:
CStone Pharmaceut Suzhou Co Ltd, Suzhou, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Ni, Jing
论文数: 0 引用数: 0
h-index: 0
机构:
CStone Pharmaceut Suzhou Co Ltd, Suzhou, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Wang, Bo
论文数: 0 引用数: 0
h-index: 0
机构:
CStone Pharmaceut Suzhou Co Ltd, Suzhou, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Xu, Yan
论文数: 0 引用数: 0
h-index: 0
机构:
CStone Pharmaceut Suzhou Co Ltd, Suzhou, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Hu, Jin
论文数: 0 引用数: 0
h-index: 0
机构:
CStone Pharmaceut Suzhou Co Ltd, Suzhou, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Shi, Qingmei
论文数: 0 引用数: 0
h-index: 0
机构:
CStone Pharmaceut Suzhou Co Ltd, Suzhou, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China

Yang, Jason
论文数: 0 引用数: 0
h-index: 0
机构:
CStone Pharmaceut Suzhou Co Ltd, Suzhou, Peoples R China Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China
[16]
First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma: a randomized phase 3 study
[J].
Jin Li
;
Zhendong Chen
;
Yuxian Bai
;
Bo Liu
;
Qingshan Li
;
Jingdong Zhang
;
Jun Zhou
;
Ting Deng
;
Fuyou Zhou
;
Shegan Gao
;
Shujun Yang
;
Feng Ye
;
Long Chen
;
Wei Bai
;
Xianli Yin
;
Shundong Cang
;
Lianke Liu
;
Yueyin Pan
;
Hui Luo
;
Yanxia Ji
;
Zhen Zhang
;
Jufeng Wang
;
Quanliang Yang
;
Na Li
;
Rong Huang
;
Chenglin Qu
;
Jing Ni
;
Bo Wang
;
Yan Xu
;
Jin Hu
;
Qingmei Shi
;
Jason Yang
.
Nature Medicine,
2024, 30
:740-748

Jin Li
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Zhendong Chen
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Yuxian Bai
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Bo Liu
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Qingshan Li
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Jingdong Zhang
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Jun Zhou
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Ting Deng
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Fuyou Zhou
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Shegan Gao
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Shujun Yang
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Feng Ye
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Long Chen
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Wei Bai
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Xianli Yin
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Shundong Cang
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Lianke Liu
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Yueyin Pan
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Hui Luo
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Yanxia Ji
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Zhen Zhang
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Jufeng Wang
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Quanliang Yang
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Na Li
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Rong Huang
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Chenglin Qu
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Jing Ni
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Bo Wang
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Yan Xu
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Jin Hu
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Qingmei Shi
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology

Jason Yang
论文数: 0 引用数: 0
h-index: 0
机构: Shanghai East Hospital,Department of Oncology
[17]
Phase II trial of cisplatin and Gemcitabine in advanced squamous-cell carcinoma of the head and neck
[J].
Hitt, R
;
Castellano, D
;
Hidalgo, M
;
García-Carbonero, R
;
Peña, M
;
Brandariz, A
;
Millán, JM
;
Vincent, JJA
;
Cortés-Funes, H
.
ANNALS OF ONCOLOGY,
1998, 9 (12)
:1347-1349

Hitt, R
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Madrid, Hosp 12 Octubre, Med Oncol Serv, Div Med Oncol Radiotherapy Head & Neck Surg & Rad, Madrid 28041, Spain Univ Madrid, Hosp 12 Octubre, Med Oncol Serv, Div Med Oncol Radiotherapy Head & Neck Surg & Rad, Madrid 28041, Spain

Castellano, D
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Madrid, Hosp 12 Octubre, Med Oncol Serv, Div Med Oncol Radiotherapy Head & Neck Surg & Rad, Madrid 28041, Spain Univ Madrid, Hosp 12 Octubre, Med Oncol Serv, Div Med Oncol Radiotherapy Head & Neck Surg & Rad, Madrid 28041, Spain

Hidalgo, M
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Madrid, Hosp 12 Octubre, Med Oncol Serv, Div Med Oncol Radiotherapy Head & Neck Surg & Rad, Madrid 28041, Spain Univ Madrid, Hosp 12 Octubre, Med Oncol Serv, Div Med Oncol Radiotherapy Head & Neck Surg & Rad, Madrid 28041, Spain

García-Carbonero, R
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Madrid, Hosp 12 Octubre, Med Oncol Serv, Div Med Oncol Radiotherapy Head & Neck Surg & Rad, Madrid 28041, Spain Univ Madrid, Hosp 12 Octubre, Med Oncol Serv, Div Med Oncol Radiotherapy Head & Neck Surg & Rad, Madrid 28041, Spain

Peña, M
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Madrid, Hosp 12 Octubre, Med Oncol Serv, Div Med Oncol Radiotherapy Head & Neck Surg & Rad, Madrid 28041, Spain Univ Madrid, Hosp 12 Octubre, Med Oncol Serv, Div Med Oncol Radiotherapy Head & Neck Surg & Rad, Madrid 28041, Spain

Brandariz, A
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Madrid, Hosp 12 Octubre, Med Oncol Serv, Div Med Oncol Radiotherapy Head & Neck Surg & Rad, Madrid 28041, Spain Univ Madrid, Hosp 12 Octubre, Med Oncol Serv, Div Med Oncol Radiotherapy Head & Neck Surg & Rad, Madrid 28041, Spain

Millán, JM
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Madrid, Hosp 12 Octubre, Med Oncol Serv, Div Med Oncol Radiotherapy Head & Neck Surg & Rad, Madrid 28041, Spain Univ Madrid, Hosp 12 Octubre, Med Oncol Serv, Div Med Oncol Radiotherapy Head & Neck Surg & Rad, Madrid 28041, Spain

Vincent, JJA
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Madrid, Hosp 12 Octubre, Med Oncol Serv, Div Med Oncol Radiotherapy Head & Neck Surg & Rad, Madrid 28041, Spain Univ Madrid, Hosp 12 Octubre, Med Oncol Serv, Div Med Oncol Radiotherapy Head & Neck Surg & Rad, Madrid 28041, Spain

Cortés-Funes, H
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Madrid, Hosp 12 Octubre, Med Oncol Serv, Div Med Oncol Radiotherapy Head & Neck Surg & Rad, Madrid 28041, Spain Univ Madrid, Hosp 12 Octubre, Med Oncol Serv, Div Med Oncol Radiotherapy Head & Neck Surg & Rad, Madrid 28041, Spain
[18]
CISPLATIN AND IFOSFAMIDE IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE UTERINE CERVIX - A PHASE-II TRIAL
[J].
CERVELLINO, JC
;
ARAUJO, CE
;
SANCHEZ, O
;
MILES, H
;
NISHIHAMA, A
.
ACTA ONCOLOGICA,
1995, 34 (02)
:257-259

CERVELLINO, JC
论文数: 0 引用数: 0
h-index: 0
机构: B HOUSSAY HOSP,ONCOL UNIT,RA-1424 BUENOS AIRES,DF,ARGENTINA

ARAUJO, CE
论文数: 0 引用数: 0
h-index: 0
机构: B HOUSSAY HOSP,ONCOL UNIT,RA-1424 BUENOS AIRES,DF,ARGENTINA

SANCHEZ, O
论文数: 0 引用数: 0
h-index: 0
机构: B HOUSSAY HOSP,ONCOL UNIT,RA-1424 BUENOS AIRES,DF,ARGENTINA

MILES, H
论文数: 0 引用数: 0
h-index: 0
机构: B HOUSSAY HOSP,ONCOL UNIT,RA-1424 BUENOS AIRES,DF,ARGENTINA

NISHIHAMA, A
论文数: 0 引用数: 0
h-index: 0
机构: B HOUSSAY HOSP,ONCOL UNIT,RA-1424 BUENOS AIRES,DF,ARGENTINA
[19]
Cost-effectiveness analysis of nivolumab combination therapy in the first-line treatment for advanced esophageal squamous-cell carcinoma
[J].
Liu, Shixian
;
Dou, Lei
;
Wang, Kaixuan
;
Shi, Zhao
;
Wang, Ruixue
;
Zhu, Xiaohong
;
Song, Zehua
;
Li, Shunping
.
FRONTIERS IN ONCOLOGY,
2022, 12

Liu, Shixian
论文数: 0 引用数: 0
h-index: 0
机构:
Shandong Univ, Cheeloo Coll Med, Ctr Hlth Management & Policy Res, Sch Publ Hlth, Jinan, Peoples R China
Shandong Univ, Natl Hlth Commiss NHC, Key Lab Hlth Econ & Policy Res, Jinan, Peoples R China
Shandong Univ, Ctr Hlth Preference Res, Jinan, Peoples R China Shandong Univ, Cheeloo Coll Med, Ctr Hlth Management & Policy Res, Sch Publ Hlth, Jinan, Peoples R China

Dou, Lei
论文数: 0 引用数: 0
h-index: 0
机构:
Shandong Univ, Cheeloo Coll Med, Ctr Hlth Management & Policy Res, Sch Publ Hlth, Jinan, Peoples R China
Shandong Univ, Natl Hlth Commiss NHC, Key Lab Hlth Econ & Policy Res, Jinan, Peoples R China
Shandong Univ, Ctr Hlth Preference Res, Jinan, Peoples R China Shandong Univ, Cheeloo Coll Med, Ctr Hlth Management & Policy Res, Sch Publ Hlth, Jinan, Peoples R China

Wang, Kaixuan
论文数: 0 引用数: 0
h-index: 0
机构:
Shandong Univ, Cheeloo Coll Med, Ctr Hlth Management & Policy Res, Sch Publ Hlth, Jinan, Peoples R China
Shandong Univ, Natl Hlth Commiss NHC, Key Lab Hlth Econ & Policy Res, Jinan, Peoples R China
Shandong Univ, Ctr Hlth Preference Res, Jinan, Peoples R China Shandong Univ, Cheeloo Coll Med, Ctr Hlth Management & Policy Res, Sch Publ Hlth, Jinan, Peoples R China

Shi, Zhao
论文数: 0 引用数: 0
h-index: 0
机构:
Shandong Univ, Cheeloo Coll Med, Ctr Hlth Management & Policy Res, Sch Publ Hlth, Jinan, Peoples R China
Shandong Univ, Natl Hlth Commiss NHC, Key Lab Hlth Econ & Policy Res, Jinan, Peoples R China
Shandong Univ, Ctr Hlth Preference Res, Jinan, Peoples R China Shandong Univ, Cheeloo Coll Med, Ctr Hlth Management & Policy Res, Sch Publ Hlth, Jinan, Peoples R China

Wang, Ruixue
论文数: 0 引用数: 0
h-index: 0
机构:
Shandong Univ, Cheeloo Coll Med, Ctr Hlth Management & Policy Res, Sch Publ Hlth, Jinan, Peoples R China
Shandong Univ, Natl Hlth Commiss NHC, Key Lab Hlth Econ & Policy Res, Jinan, Peoples R China
Shandong Univ, Ctr Hlth Preference Res, Jinan, Peoples R China Shandong Univ, Cheeloo Coll Med, Ctr Hlth Management & Policy Res, Sch Publ Hlth, Jinan, Peoples R China

Zhu, Xiaohong
论文数: 0 引用数: 0
h-index: 0
机构:
Shandong Univ, Cheeloo Coll Med, Ctr Hlth Management & Policy Res, Sch Publ Hlth, Jinan, Peoples R China
Shandong Univ, Natl Hlth Commiss NHC, Key Lab Hlth Econ & Policy Res, Jinan, Peoples R China
Shandong Univ, Ctr Hlth Preference Res, Jinan, Peoples R China Shandong Univ, Cheeloo Coll Med, Ctr Hlth Management & Policy Res, Sch Publ Hlth, Jinan, Peoples R China

Song, Zehua
论文数: 0 引用数: 0
h-index: 0
机构:
Shandong Univ, Cheeloo Coll Med, Ctr Hlth Management & Policy Res, Sch Publ Hlth, Jinan, Peoples R China
Shandong Univ, Natl Hlth Commiss NHC, Key Lab Hlth Econ & Policy Res, Jinan, Peoples R China
Shandong Univ, Ctr Hlth Preference Res, Jinan, Peoples R China Shandong Univ, Cheeloo Coll Med, Ctr Hlth Management & Policy Res, Sch Publ Hlth, Jinan, Peoples R China

Li, Shunping
论文数: 0 引用数: 0
h-index: 0
机构:
Shandong Univ, Cheeloo Coll Med, Ctr Hlth Management & Policy Res, Sch Publ Hlth, Jinan, Peoples R China
Shandong Univ, Natl Hlth Commiss NHC, Key Lab Hlth Econ & Policy Res, Jinan, Peoples R China
Shandong Univ, Ctr Hlth Preference Res, Jinan, Peoples R China Shandong Univ, Cheeloo Coll Med, Ctr Hlth Management & Policy Res, Sch Publ Hlth, Jinan, Peoples R China
[20]
Phase II study of irinotecan in combination with capecitabine as a first-line chemotherapy in Asian patients with inoperable hepatocellular carcinoma
[J].
Mok, Tony
;
Yang, Tsai-Shen
;
Chao, Yee
;
Wang, Cheng-Hsu
;
Liu, Mei-Ching
;
Kang, Yoon Koo
;
Kang, Won Ki
;
Kim, Jun Suk
;
Wang, Yajie
;
Leung, Thomas
.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY,
2009, 5 (02)
:95-100

Mok, Tony
论文数: 0 引用数: 0
h-index: 0
机构:
Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China

Yang, Tsai-Shen
论文数: 0 引用数: 0
h-index: 0
机构:
Chang Gung Mem Hosp, Tao Yuan, Taiwan Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China

Chao, Yee
论文数: 0 引用数: 0
h-index: 0
机构:
Taipei Vet Gen Hosp, Taipei 112, Taiwan Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China

Wang, Cheng-Hsu
论文数: 0 引用数: 0
h-index: 0
机构:
Chang Gung Mem Hosp, Chilung, Taiwan Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China

Liu, Mei-Ching
论文数: 0 引用数: 0
h-index: 0
机构:
Sun Yat Sen Canc Ctr, Taipei, Taiwan Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China

Kang, Yoon Koo
论文数: 0 引用数: 0
h-index: 0
机构: Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China

Kang, Won Ki
论文数: 0 引用数: 0
h-index: 0
机构: Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China

Kim, Jun Suk
论文数: 0 引用数: 0
h-index: 0
机构:
Korea Univ, Guro Hosp, Seoul, South Korea Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China

Wang, Yajie
论文数: 0 引用数: 0
h-index: 0
机构:
Mil Med Univ Shanghai, Changhai Hosp, Shanghai, Peoples R China Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China

Leung, Thomas
论文数: 0 引用数: 0
h-index: 0
机构: Chinese Univ Hong Kong, Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China